Alliance for Clinical Trials in Oncology’s Post

For #TrialTuesday, Haeseong Park, MD, PhD, of Dana-Farber Cancer Institute, lead the Alliance A022102 trial that compares the effect of mFOLFIRINOX versus mFOLFOX with or without nivolumab to treat patients with #metastatic HER2 negative #gastroesophageal cancer. To learn more about this trial, visit https://lnkd.in/g3jFJnRR #NCI #NCTN #gastriccancer

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics